{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:45:13Z","timestamp":1791305113585,"version":"4.3.1"},"reference-count":50,"publisher":"Rockefeller University Press","issue":"7","content-domain":{"domain":["rupress.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[1999,4,5]]},"abstract":"<jats:p>Fas antigen (Apo-1\/CD95) is an apoptosis-signaling cell surface receptor belonging to the tumor necrosis factor receptor superfamily. Adult T cell leukemia (ATL) cells express Fas antigen and show apoptosis after treatment with an anti-Fas monoclonal antibody. We established the ATL cell line KOB, which showed resistance to Fas-mediated apoptosis, and found that KOB expressed two forms of Fas mRNA, the normal form and a truncated form. The truncated transcript lacked 20 base pairs at exon 9, resulting in a frame shift and the generation of a premature stop codon at amino acid 239. The same mutation was detected in primary ascitic cells and peripheral blood cells. The mutation was not detected in lymph node cells, however, although all of the primary ATL cells were of the same clonal origin. A retroviral-mediated gene transfer of the truncated Fas to Jurkat cells rendered the cells resistant to Fas-mediated apoptosis, suggesting a dominant negative interference mechanism. These results indicate that an ATL subclone acquires a Fas mutation in the lymph nodes, enabling the subclone to escape from apoptosis mediated by the Fas\/Fas ligand system and proliferate in the body. Mutation of the Fas gene may be one of the mechanisms underlying the progression of ATL.<\/jats:p>","DOI":"10.1084\/jem.189.7.1063","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T16:48:33Z","timestamp":1027702113000},"page":"1063-1071","update-policy":"https:\/\/doi.org\/10.1084\/jem.crossmarkpolicy","source":"Crossref","is-referenced-by-count":113,"title":["Fas Gene Mutation in the Progression of Adult T Cell Leukemia"],"prefix":"10.1084","volume":"189","author":[{"given":"Takahiro","family":"Maeda","sequence":"first","affiliation":[{"name":"From the *Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, the \u2021Department of Laboratory Medicine, and the \u00a7Department of Bacteriology, Nagasaki University School of Medicine, Nagasaki 852-8102, Japan; and the \u2016Department of Laboratory Chemotherapy, Aichi Cancer Center, Aichi 464-0021, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuaki","family":"Yamada","sequence":"additional","affiliation":[{"name":"From the *Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, the \u2021Department of Laboratory Medicine, and the \u00a7Department of Bacteriology, Nagasaki University School of Medicine, Nagasaki 852-8102, Japan; and the \u2016Department of Laboratory Chemotherapy, Aichi Cancer Center, Aichi 464-0021, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryozou","family":"Moriuchi","sequence":"additional","affiliation":[{"name":"From the *Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, the \u2021Department of Laboratory Medicine, and the \u00a7Department of Bacteriology, Nagasaki University School of Medicine, Nagasaki 852-8102, Japan; and the \u2016Department of Laboratory Chemotherapy, Aichi Cancer Center, Aichi 464-0021, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyuki","family":"Sugahara","sequence":"additional","affiliation":[{"name":"From the *Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, the \u2021Department of Laboratory Medicine, and the \u00a7Department of Bacteriology, Nagasaki University School of Medicine, Nagasaki 852-8102, Japan; and the \u2016Department of Laboratory Chemotherapy, Aichi Cancer Center, Aichi 464-0021, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuto","family":"Tsuruda","sequence":"additional","affiliation":[{"name":"From the *Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, the \u2021Department of Laboratory Medicine, and the \u00a7Department of Bacteriology, Nagasaki University School of Medicine, Nagasaki 852-8102, Japan; and the \u2016Department of Laboratory Chemotherapy, Aichi Cancer Center, Aichi 464-0021, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsurou","family":"Joh","sequence":"additional","affiliation":[{"name":"From the *Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, the \u2021Department of Laboratory Medicine, and the \u00a7Department of Bacteriology, Nagasaki University School of Medicine, Nagasaki 852-8102, Japan; and the \u2016Department of Laboratory Chemotherapy, Aichi Cancer Center, Aichi 464-0021, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunao","family":"Atogami","sequence":"additional","affiliation":[{"name":"From the *Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, the \u2021Department of Laboratory Medicine, and the \u00a7Department of Bacteriology, Nagasaki University School of Medicine, Nagasaki 852-8102, Japan; and the \u2016Department of Laboratory Chemotherapy, Aichi Cancer Center, Aichi 464-0021, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunihiro","family":"Tsukasaki","sequence":"additional","affiliation":[{"name":"From the *Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, the \u2021Department of Laboratory Medicine, and the \u00a7Department of Bacteriology, Nagasaki University School of Medicine, Nagasaki 852-8102, Japan; and the \u2016Department of Laboratory Chemotherapy, Aichi Cancer Center, Aichi 464-0021, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Tomonaga","sequence":"additional","affiliation":[{"name":"From the *Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, the \u2021Department of Laboratory Medicine, and the \u00a7Department of Bacteriology, Nagasaki University School of Medicine, Nagasaki 852-8102, Japan; and the \u2016Department of Laboratory Chemotherapy, Aichi Cancer Center, Aichi 464-0021, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimeru","family":"Kamihira","sequence":"additional","affiliation":[{"name":"From the *Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, the \u2021Department of Laboratory Medicine, and the \u00a7Department of Bacteriology, Nagasaki University School of Medicine, Nagasaki 852-8102, Japan; and the \u2016Department of Laboratory Chemotherapy, Aichi Cancer Center, Aichi 464-0021, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"291","published-online":{"date-parts":[[1999,4,5]]},"reference":[{"key":"2023072508380169800_B1","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0092-8674(91)90614-5","article-title":"The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis","volume":"66","author":"Itoh","year":"1991","journal-title":"Cell"},{"key":"2023072508380169800_B2","doi-asserted-by":"crossref","first-page":"10932","DOI":"10.1016\/S0021-9258(18)82075-0","article-title":"A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen","volume":"268","author":"Itoh","year":"1993","journal-title":"J Biol Chem"},{"key":"2023072508380169800_B3","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1126\/science.7510905","article-title":"Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule","volume":"263","author":"Cheng","year":"1994","journal-title":"Science"},{"key":"2023072508380169800_B4","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.4049\/jimmunol.154.6.2706","article-title":"Three functional soluble forms of the human apoptosis- inducing Fas molecule are produced by alternative splicing","volume":"154","author":"Cascino","year":"1995","journal-title":"J Immunol"},{"key":"2023072508380169800_B5","doi-asserted-by":"crossref","first-page":"4622","DOI":"10.4049\/jimmunol.156.12.4622","article-title":"An N-terminal domain shared by Fas\/ Apo-1 (CD95) soluble variants prevents cell death in vitro","volume":"156","author":"Papoff","year":"1996","journal-title":"J Immunol"},{"key":"2023072508380169800_B6","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/0167-5699(95)80079-4","article-title":"Fas and FasL in the homeostatic regulation of immune responses","volume":"16","author":"Lynch","year":"1995","journal-title":"Immunol Today"},{"key":"2023072508380169800_B7","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0092-8674(00)81874-7","article-title":"Apoptosis by death factor","volume":"88","author":"Nagata","year":"1997","journal-title":"Cell"},{"key":"2023072508380169800_B8","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/356314a0","article-title":"Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis","volume":"356","author":"Watanabe-Fukunaga","year":"1992","journal-title":"Nature"},{"key":"2023072508380169800_B9","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1073\/pnas.90.5.1756","article-title":"Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice","volume":"90","author":"Adachi","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"2023072508380169800_B10","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0167-5699(95)80069-7","article-title":"Fas and Fas ligand: lpr and gld mutations","volume":"16","author":"Nagata","year":"1995","journal-title":"Immunol Today"},{"key":"2023072508380169800_B11","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/0092-8674(95)90013-6","article-title":"Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome","volume":"81","author":"Fisher","year":"1995","journal-title":"Cell"},{"key":"2023072508380169800_B12","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1126\/science.7539157","article-title":"Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity","volume":"268","author":"Rieux-Laucat","year":"1995","journal-title":"Science"},{"key":"2023072508380169800_B13","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1182\/blood.V89.3.902","article-title":"Missense mutations in the Fas gene resulting in autoimmune lymphoproliferative syndrome: a molecular and immunological analysis","volume":"89","author":"Bettinardi","year":"1997","journal-title":"Blood"},{"key":"2023072508380169800_B14","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1056\/NEJM199611283352204","article-title":"Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity","volume":"335","author":"Drappa","year":"1996","journal-title":"N Engl J Med"},{"key":"2023072508380169800_B15","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1182\/blood.V50.3.481.481","article-title":"Adult T-cell leukemia: clinical and hematologic features of 16 cases","volume":"50","author":"Uchiyama","year":"1977","journal-title":"Blood"},{"key":"2023072508380169800_B16","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1182\/blood.V61.1.192.192","article-title":"Phenotypic and functional analysis of leukemic cells from 16 patients with adult T-cell leukemia\/lymphoma","volume":"61","author":"Yamada","year":"1983","journal-title":"Blood"},{"key":"2023072508380169800_B17","doi-asserted-by":"crossref","first-page":"7415","DOI":"10.1073\/pnas.77.12.7415","article-title":"Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma","volume":"77","author":"Poiesz","year":"1980","journal-title":"Proc Natl Acad Sci USA"},{"key":"2023072508380169800_B18","doi-asserted-by":"crossref","first-page":"6476","DOI":"10.1073\/pnas.78.10.6476","article-title":"Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera","volume":"78","author":"Hinuma","year":"1981","journal-title":"Proc Natl Acad Sci USA"},{"key":"2023072508380169800_B19","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1073\/pnas.81.8.2534","article-title":"Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease","volume":"81","author":"Yoshida","year":"1984","journal-title":"Proc Natl Acad Sci USA"},{"key":"2023072508380169800_B20","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1365-2141.1991.tb08051.x","article-title":"Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984\u201387)","volume":"79","author":"Shimoyama","year":"1991","journal-title":"Br J Haematol"},{"key":"2023072508380169800_B21","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1200\/JCO.1988.6.1.128","article-title":"Chemotherapeutic results and prognostic factors of patients with advanced non-Hodgkin's lymphoma treated with VEPA or VEPA-M","volume":"6","author":"Shimoyama","year":"1988","journal-title":"J Clin Oncol"},{"key":"2023072508380169800_B22","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/0140-6736(90)90735-N","article-title":"Monoclonal-antibody- mediated apoptosis in adult T cell leukaemia","volume":"335","author":"Debatin","year":"1990","journal-title":"Lancet"},{"key":"2023072508380169800_B23","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1182\/blood.V81.11.2972.2972","article-title":"APO-1-induced apoptosis of leukemia cells from patients with adult T-cell leukemia","volume":"81","author":"Debatin","year":"1993","journal-title":"Blood"},{"key":"2023072508380169800_B24","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/(SICI)1097-0215(19970703)72:1<128::AID-IJC18>3.0.CO;2-F","article-title":"Soluble and membrane isoforms of Fas\/CD95 in fresh adult T-cell leukemia (ATL) cells and ATL-cell lines","volume":"72","author":"Sugahara","year":"1997","journal-title":"Int J Cancer"},{"key":"2023072508380169800_B25","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1046\/j.1365-2141.1997.4963301.x","article-title":"Quantitative characterization and potential function of membrane Fas\/APO-1 (CD95) receptors on leukaemic cells from chronic B and T lymphoid leukaemias","volume":"99","author":"Kamihira","year":"1997","journal-title":"Br J Haematol"},{"key":"2023072508380169800_B26","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.1182\/blood.V90.11.4266","article-title":"Mutations in the Fas antigen in patients with multiple myeloma","volume":"90","author":"Landowski","year":"1997","journal-title":"Blood"},{"key":"2023072508380169800_B27","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1182\/blood.V91.10.3943","article-title":"CD95 (APO-1\/Fas) mutations in childhood T-lineage acute lymphoblastic leukemia","volume":"91","author":"Beltinger","year":"1998","journal-title":"Blood"},{"key":"2023072508380169800_B28","doi-asserted-by":"crossref","first-page":"3935","DOI":"10.1182\/blood.V91.10.3935","article-title":"Mutation of CD95 (Fas\/Apo-1) gene in adult T-cell leukemia cells","volume":"91","author":"Tamiya","year":"1998","journal-title":"Blood"},{"key":"2023072508380169800_B29","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1365-2141.1994.tb05012.x","article-title":"Established IL-2-dependent double-negative (CD4\u2212 CD8\u2212) TCR alpha beta\/CD3+ ATL cells: induction of CD4 expression","volume":"88","author":"Yamada","year":"1994","journal-title":"Br J Haematol"},{"key":"2023072508380169800_B30","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3109\/10428199609093442","article-title":"Features of the cytokines secreted by adult T cell leukemia (ATL) cells","volume":"21","author":"Yamada","year":"1996","journal-title":"Leuk Lymphoma"},{"key":"2023072508380169800_B31","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/0145-2126(92)90168-7","article-title":"Phenotypic diversity and prognosis of adult T-cell leukemia","volume":"16","author":"Kamihira","year":"1992","journal-title":"Leuk Res"},{"key":"2023072508380169800_B32","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0145-2126(93)90061-O","article-title":"Characteristics of chemotherapy-induced clinical remission in long survivors with aggressive adult T-cell leukemia\/lymphoma","volume":"17","author":"Tsukasaki","year":"1993","journal-title":"Leuk Res"},{"key":"2023072508380169800_B33","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0145-2126(94)90034-5","article-title":"Expression of functional Fas antigen on adult T-cell leukemia","volume":"18","author":"Kotani","year":"1994","journal-title":"Leuk Res"},{"key":"2023072508380169800_B34","doi-asserted-by":"crossref","first-page":"166","DOI":"10.2169\/internalmedicine.36.166","article-title":"Serum levels of soluble Fas\/APO-1 receptor in human retroviral infection and associated diseases","volume":"36","author":"Kamihira","year":"1997","journal-title":"Intern Med"},{"key":"2023072508380169800_B35","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1093\/ajcp\/104.4.424","article-title":"Search for rearrangements and\/or allelic loss of the fas\/APO-1 gene in 101 human lymphomas","volume":"104","author":"Xerri","year":"1995","journal-title":"Am J Clin Pathol"},{"key":"2023072508380169800_B36","first-page":"671","article-title":"Inhibition of tyrosine kinase activity of the epidermal growth factor (EGF) receptor by a truncated receptor form that binds to EGF: role for interreceptor interaction in kinase regulation","volume":"9","author":"Basu","year":"1989","journal-title":"Mol Cell Biol"},{"key":"2023072508380169800_B37","first-page":"1454","article-title":"A dominant negative mutation suppresses the function of normal epidermal growth factor receptors by heterodimerization","volume":"11","author":"Kashles","year":"1991","journal-title":"Mol Cell Biol"},{"key":"2023072508380169800_B38","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0092-8674(91)90616-7","article-title":"Expression of a dominant negative mutant of the FGF receptor disrupts mesoderm formation in Xenopusembryos","volume":"66","author":"Amaya","year":"1991","journal-title":"Cell"},{"key":"2023072508380169800_B39","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/S0021-9258(18)45969-8","article-title":"A truncated form of fibroblast growth factor receptor 1 inhibits signal transduction by multiple types of fibroblast growth factor receptor","volume":"267","author":"Ueno","year":"1992","journal-title":"J Biol Chem"},{"key":"2023072508380169800_B40","first-page":"7660","article-title":"Cell transformation by fibroblast growth factors can be suppressed by truncated fibroblast growth factor receptors","volume":"14","author":"Li","year":"1994","journal-title":"Mol Cell Biol"},{"key":"2023072508380169800_B41","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1126\/science.1851331","article-title":"Inhibition of PDGF beta receptor signal transduction by coexpression of a truncated receptor","volume":"252","author":"Ueno","year":"1991","journal-title":"Science"},{"key":"2023072508380169800_B42","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0092-8674(93)90132-A","article-title":"Crystal structure of the soluble human 55 kd TNF receptor- human TNF beta complex: implications for TNF receptor activation","volume":"73","author":"Banner","year":"1993","journal-title":"Cell"},{"key":"2023072508380169800_B43","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/j.1460-2075.1995.tb07096.x","article-title":"Expression of the functional soluble form of human fas ligand in activated lymphocytes","volume":"14","author":"Tanaka","year":"1995","journal-title":"EMBO J"},{"key":"2023072508380169800_B44","doi-asserted-by":"crossref","first-page":"5579","DOI":"10.1002\/j.1460-2075.1995.tb00245.x","article-title":"Cytotoxicity-dependent APO 1(Fas\/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor","volume":"14","author":"Kischkel","year":"1995","journal-title":"EMBO J"},{"key":"2023072508380169800_B45","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1349-7006.1989.tb02289.x","article-title":"Multi-step carcinogenesis model for adult T-cell leukemia","volume":"80","author":"Okamoto","year":"1989","journal-title":"Jpn J Cancer Res"},{"key":"2023072508380169800_B46","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1182\/blood.V79.2.477.477","article-title":"Mutations of the p53 gene in adult T cell leukemia","volume":"79","author":"Sakashita","year":"1992","journal-title":"Blood"},{"key":"2023072508380169800_B47","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1182\/blood.V85.10.2699.bloodjournal85102699","article-title":"Homozygous deletions of the p15 (MTS2) and p16 (CDKN2\/MTS1) genes in adult T-cell leukemia","volume":"85","author":"Hatta","year":"1995","journal-title":"Blood"},{"key":"2023072508380169800_B48","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1200\/JCO.1997.15.5.1778","article-title":"Deletions of p15 and\/or p16 genes as a poor-prognosis factor in adult T-cell leukemia","volume":"15","author":"Yamada","year":"1997","journal-title":"J Clin Oncol"},{"key":"2023072508380169800_B49","first-page":"2397","article-title":"Loss of Fas\/Apo-1 receptor accelerates lymphomagenesis in E mu L-MYC transgenic mice but not in animals infected with MoMuLV","volume":"10","author":"Zornig","year":"1995","journal-title":"Oncogene"},{"key":"2023072508380169800_B50","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1084\/jem.184.3.1149","article-title":"A tumor-suppressor function for Fas (CD95) revealed in T cell\u2013 deficient mice","volume":"184","author":"Peng","year":"1996","journal-title":"J Exp Med"}],"container-title":["The Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/rupress.org\/jem\/article-pdf\/189\/7\/1063\/1693394\/98-2105.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/rupress.org\/jem\/article-pdf\/189\/7\/1063\/1693394\/98-2105.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T09:50:25Z","timestamp":1690278625000},"score":1,"resource":{"primary":{"URL":"https:\/\/rupress.org\/jem\/article\/189\/7\/1063\/7952\/Fas-Gene-Mutation-in-the-Progression-of-Adult-T"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,4,5]]},"references-count":50,"journal-issue":{"issue":"7","published-print":{"date-parts":[[1999,4,5]]}},"URL":"https:\/\/doi.org\/10.1084\/jem.189.7.1063","relation":{},"ISSN":["0022-1007","1540-9538"],"issn-type":[{"value":"0022-1007","type":"print"},{"value":"1540-9538","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,4,5]]}}}